[1]
Gorobets, L. and Litvinov, A. 2020. CARIPRAZINE: NEUROENDOCRINE AND METABOLIC ASPECTS OF TOLERANCE IN PATIENTS WITH MENTAL DISORDERS. Current Therapy of Mental Disorders. 3 (Sep. 2020), 19–27. DOI:https://doi.org/10.21265/PSYPH.2020.79.49.003.